Alzheimer's disease (AD) is pathologically characterized by amyloid-b peptide (Ab) accumulation, neurofibrillary tangle formation, and neurodegeneration. Preclinical studies on neuronal impairments associated with progressive amyloidosis have demonstrated some Ab-dependent neuronal dysfunction including modulation of gamma-aminobutyric acid-ergic signaling. The present work focuses on the early stage of disease progression and uses TgF344-AD rats that recapitulate a broad repertoire of AD-like pathologies to investigate the neuronal network functioning using simultaneous intracranial recordings from the hippocampus (HPC) and the medial prefrontal cortex (mPFC), followed by pathological analyses of gamma-aminobutyric acid (GABA A ) receptor subunits a1 , a5, and d, and glutamic acid decarboxylases (GAD65 and GAD67). Concomitant to amyloid deposition and tau hyperphosphorylation, lowgamma band power was strongly attenuated in the HPC and mPFC of TgF344-AD rats in comparison to those in non-transgenic littermates. In addition, the phase-amplitude coupling of the neuronal networks in both areas was impaired, evidenced by decreased modulation of theta band phase on gamma band amplitude in TgF344-AD animals. Finally, the gamma coherence between HPC and mPFC was attenuated as well. These results demonstrate significant neuronal network dysfunction at an early stage of AD-like pathology. This network dysfunction precedes the onset of cognitive deficits and is likely driven by Ab and tau pathologies.
depend on the balance between excitatory and inhibitory activity. Alzheimer's disease (AD) patients present a reduced coupling of resting state EEG rhythms among cortical regions (Jelic et al. 1997; Locatelli et al. 1998; Wada et al. 1998; Knott et al. 2000) , and between hippocampus and prefrontal cortex (Grady et al. 2001; Ries et al. 2012) , which suggests that alteration in coupling of specific frequency bands and aberrant EEG coherence may be specific markers of AD. Even if the biological correlate of altered EEG coherence is yet to be discovered, mounting evidence suggests modulation of gamma-aminobutyric acid-ergic (GABAergic) signaling in AD pathogenesis. In particular, reduced expression of post-synaptic GABA A receptors has been observed in humans and in transgenic mice models; and biphasic changes in pre-synaptic GABA receptors were reported, with early elevation followed by decline in the late stages of the disease (for a review, see Li et al. 2016) .
Cortical and subcortical neuronal networks are organized in motifs characterized by connectivity map and neuronalactivation frequency signature. These properties underlie the input-output transformation operated by the motif that ultimately implements a behavioral function. Frequencyspecific activity pattern and neuronal-activation signature complete a dynamic motif and are linked to a precise function (Womelsdorf et al. 2014) . The balance between GABAergic inhibition and glutamatergic excitation determines when (and how fast) pyramidal cells recover from inhibition and reactivate the interneurons (Borgers et al. 2008; de Almeida et al. 2009; Tiesinga and Sejnowski 2009) . It has been speculated that the impairment in EEG functional coupling is modulated by the cholinergic system and that the decreased cortical EEG coherence results from aberrant basal forebrain cholinergic inputs to the cortex and hippocampus (Locatelli et al. 1998; Lizio et al. 2011) . Hence, amplitude modulation analysis of resting neuronal oscillations in cortex and hippocampus has been suggested as a promising tool to characterize different neurological disorders (Smit et al. 2011; Hardstone et al. 2012) including early-stage AD (Trambaiolli et al. 2011; Fraga et al. 2013) . Further, AD progression is accompanied by compromised cerebrovascular reactivity (Dorr et al. 2012; Iturria-Medina et al. 2016 ) and vascular response is known to be regulated by gamma-band activity (Niessing et al. 2005; Goense and Logothetis 2008; Koch et al. 2009 ).
Thus far, the majority of neuronal and cerebrovascular dysfunction associated with AD pathologies has been observed in transgenic murine models of progressive amyloidosis (Dorr et al. 2012; Kara et al. 2012; Park et al. 2013; Lai et al. 2015) . In comparison, triple transgenic mice that exhibit both Ab and tau pathology showed accelerated rate of neuronal compromise and late stage, Ab-independent neuronal loss, indicating a significant role of tauopathy in AD pathogenesis (Oddo et al. 2003; Bittner et al. 2010) . Furthermore, the rise in soluble Ab levels may lead to neuronal alterations including tau hyperphosphorylation (Jin et al. 2011 ) and synaptic dysfunction (Klyubin et al. 2005; Shankar et al. 2008) . Ab accumulation and NFT formation both contribute to neurotoxicity (Ittner and Gotz 2011) and exacerbate neurodegeneration (Rhein et al. 2009; Ittner and Gotz 2011) , yet their cumulative effect on neuronal network function remains unclear. It is thus of particular importance to examine the neuronal functioning in the presence of both amyloid and tau pathologies. To address this issue, we used the novel TgF344-AD rat model that presents progressive amyloidosis, tauopathy, and frank neuronal loss in addition to cognitive decline (Cohen et al. 2013) , to investigate for the first time the early neuronal network impairment in the hippocampus (HPC) and medial prefrontal cortex (mPFC). We chose to examine neuronal function and GABAergic system after the appearance of amyloid plaques and tau hyperphosphorylation, but before the onset of significant cognitive symptomatology, hence focusing on animals of 8-9 months of age (Cohen et al. 2013) . We hypothesized that TgF344-AD animals at this disease stage would present neuronal activity changes in the HPC and mPFC, as these brain regions have been demonstrated particularly susceptible to AD pathology and are involved in cognitive functions that get impaired very early in the disease process. Neuronal functioning was assessed by estimating neuronal power spectrum and phase-amplitude coupling (PAC) between theta and gamma bands in each region, as well as mPFC-HPC coherence. These spectral analyses were used to examine the balance between activities of specific neuronal subpopulations. In particular, since the firing rate of parvalbuminexpressing interneurons directly governs the power of gamma oscillations but not of other oscillations, gamma power reflects parvalbumin cells' activity; in turn, the firing rate of pyramidal cells specifically relates to the power of low-frequency oscillations (Cardin et al. 2009; Sohal et al. 2009 ). In addition to in situ electrophysiological recordings, histological analyses were used to examine Ab accumulation and the inhibitory circuitry, by assessing expression levels of GABA A receptor subunits a1 , a5, and d, as well as glutamic acid decarboxylases GAD65 and GAD67.
Material and methods
All experimental procedures in this study were approved by the Animal Care Committee of the Sunnybrook Research Institute, which adheres to the Policies and Guidelines of the Canadian Council on Animal Care and meets all the requirements of the Provincial Statute of Ontario, Animals for Research Act as well as those of the Canadian Federal Health of Animals Act. Ten 8 to 9-month-old TgF344-AD rats (four males and six females) on the Fisher 344 background, over-expressing APPsw and D exon 9 mutant human presenilin-1 (PS1DE9) under mouse prion protein promoter and 10 age-matched homozygous non-transgenic (nTg, six males and four females) littermates were included in this study. Four (two males and two females) TgF344-AD and four (three males and one female) nTg rats were used for electrophysiological experiments, while six TgF344-AD rats (two males and four females) and six nTg rats (three males and three females) were used for immunohistopathology. Given the sample size and the respective level of noise, we were thus powered to detect 30, 20, and 20% differences in spontaneous power, coherence and modulation index, respectively. The subjects were bred at the vivarium of the Sunnybrook Research Institute and were kept on a 12 : 12 light/ dark cycle with water and food ad libitum.
Electrophysiological recordings
Animals were anesthetised with isofluorane (5% induction and 2-2.5% maintenance) and positioned in a stereotaxic frame (David KOPF Instruments, Tujunga, CA, USA). An intravenous catheter was inserted in the tail vein for delivery of anesthesia during the recordings. Using a high-speed micro-drill (Foredom Electric Co., Bethel, CT, USA), skull was removed to expose dura, which was carefully resected, to create two cranial windows in the same hemisphere, such that the centers of the craniotomies were situated over the prefrontal cortex (AP +3.5 mm, ML AE 0.5 mm) and somatosensory region (AP-3.0 mm, ML AE 0.5 mm). At the end of the surgery, isoflurane was gradually discontinued and animals were administered a bolus of propofol (7.5 mg/kg b.w.) followed by continuous intravenous infusion (44.0 mg/kg/h) via the tail vein to maintain a light sedative state. A two-shank linear multielectrode array was lowered into each one of the windows. Each shank was equipped with one platinum/iridium recording site (200 lm in diameter, Microprobes for LifeScience). Resting-state local field potentials were amplified (AM-systems 3600, Sequim, WA, USA) between 0.3 Hz and 5 kHz, sampled at 20 kHz (DataWave, Loveland, CO, USA) and stored on a desktop computer for offline analysis.
Electrophysiological data analysis
Power line noise (60 Hz) and its harmonics were removed via notch filtering before additional analysis using a zero-phase forward and reverse Butterworth infinite impulse response filter with frequency range of AE 2 Hz around the stop band (filtfilt.m in Matlab; MathWorks, Natick, MA, USA) to eliminate phase distortions. Recordings were re-referenced offline between the two recording sites within every brain area. To estimate power, the fast Fourier transform was computed for all 3-second intervals in each 5-min epoch using a non-overlapping running window within each channel. The relative power was calculated as the fraction of a specific frequency band power in the total power over all frequency bands. The frequency band of interest were theta (3-9 Hz), alpha (10-14 Hz), beta (15-30 Hz), low gamma (30-58) and high gamma (62-120 Hz). These frequency bands have been hypothesized to arise from dynamic motifs that are based on structural circuits and that dictate behavioral function, after input-output transformation (Womelsdorf et al. 2014) . The phenomenon by which one frequency band can modulate the activity of a different frequency band has been observed in both animal and human data and is termed cross-frequency coupling ( (Canolty and Knight 2010) and references therein). The events of interest in cross-frequency coupling are features of the ongoing oscillatory activity itself; therefore, cross-frequency coupling refers to statistical dependence between distinct frequencies bands of the ongoing electrical activity rather than dependence of the electrical activity on external stimulus events. Specifically, the theta rhythm can modulate the gamma power of the intracortical local field potential (Bragin et al. 1995; Chrobak and Buzsaki 1998; Lee et al. 2005) . High-gamma activity is modulated by sensory, motor, and cognitive events (Crone et al. 1998) , is functionally distinct from low gamma, and has distinct physiological origins (Edwards et al. 2005) . Here, we focus on the phase-amplitude coupling and use an index of cross-frequency coupling referred to as modulation index (MI) that combines the amplitude envelope of time series (A) at different time lag (s): A 1 (t + s) of a high-frequency band with the phase time series φ 2 (t) of a low-frequency band into one composite, complex-valued signal z (t, s). The temporal mean of this composite signal provides a sensitive measure of the coupling strength and preferred phase between the two frequencies (Canolty et al. 2006) . The MI was estimated with Matlab Toolbox by Onslow (Onslow et al. 2011) (https://www.cs.bris.ac.uk/Research/MachineLearning/pac/).
To estimate cross-frequency coupling, we adopted the method presented by Canolty (Canolty et al. 2006) , where the highfrequency amplitude envelope and the low-frequency instantaneous phase comprise the amplitude and phase of the complex-valued composite signal. A population of 50 shuffled signals were created and compared to the original signal to generate a distribution of MI values. MI values lying in the top 5% of this distribution (after Bonferroni correction) were deemed significant. Theta band was divided into 0.5 Hz bins, while both gamma bands were binned every 2 Hz.
The coherence between the EEG channel in the hippocampus and the one in medial prefrontal cortex was measured by amplitude squared coherence (mscohere.m function in Matlab signal toolbox), which computes coherence of the input signals x and y using Welch's averaged, modified periodogram method. The magnitude squared coherence estimate C xy (f) indicates how well x corresponds to y at each frequency:
C xy ðf Þ ¼ jP xy ðf Þj=P xx ðf Þ Â P yy ðf Þ; 0\C xy \1 where P xx (f) and P yy (f) are the power spectral densities of the input signals x and y and P xy is the cross-power spectral density. For each subject, the mean coherence between the electrode in the hippocampus and in the medial prefrontal cortex was calculated. Specifically, the local field potential signal was segmented into 3-second long, non-overlapping, epochs and the magnitude squared coherence estimated for each epoch and frequency bin for each animal. The bins were 0.3 Hz wide and spanned the frequency range from 2 to 120 Hz.
Immunohistochemistry
Tissues were fixed with 4% paraformaldehyde in phosphatebuffered saline (PBS), followed by cryoprotection with 30% sucrose in PBS. Tissues were sectioned at 40 lm via freezing sliding microtome (Leica Biosystems, Concord, ON, Canada) and stored in tissue collecting solution cryoprotectant (25% glycerol, 30% ethylene glycol, 0.05 M PO4) at À20°C until use. Sections from the medial prefrontal cortex and hippocampus were treated with 1% hydrogen peroxide in PBS (30 min) to eliminate endogenous peroxide activity prior to blocking with 0.2% triton and 0.2% bovine serum albumin in PBS (PBS++) with 5% serum (1 h). Primary antibody to GAD67 was diluted in PBS++ with 5% serum (1 : 1000 (#MAB5406); EMD Millipore, Etobicoke, ON, Canada) and incubated overnight. Secondary antibodies (biotinylated anti-Mo; Vector Laboratories, Burlington, ON, Canada) were incubated for 1.5 h (in PBS++) followed by 1 h in ABC reagent (Vector Laboratories). Sections were developed with DAB (Vector Laboratories), dehydrated, and mounted with Cytoseal XYL (Thermo Fisher Scientific, Burlington, ON, Canada).
Plaque count
Ab plaque load was quantified by 6F3D labeling. Floating coronal sections of 40 lm thickness were quenched with 3% hydrogen peroxide (in PBS) for 30 min before 70% formic acid (in water) retrieval for 7 min. The sections were then incubated with the 6F3D antibody (in PBS with 0.25% Triton and 0.2% bovine serum albumin) at 24°C overnight, the biotinylated anti-IgG for 2 h (in PBS with 0.25% Triton and 0.2% bovine serum albumin, 1 : 400, PK4002; Vector), and the avidin complex for 1 h (in PBS, 1 : 200, PK4002; Vector) before development with diaminobenzidine (SK4100; Vector). Bright-field micrographs (stitched image of the whole section) of six sections per brain were acquired with a 49 objective using Stereo Investigator (MBF Bioscience, Williston, VT, USA) and analyzed with ImageJ. The threshold range for delineation of Ab plaque from background was set such that the smallest plaques (~100 lm 2 in area)
were preserved. Ab plaque load is expressed as Ab plaque count per unit area (count/mm 2 ), where the total Ab plaque count in the given region (i.e., prefrontal cortex, hippocampus or both) is divided by the total area of the same brain region.
Immunoblots
Tissues from 8.5-month-old rats were initially extracted in sucrose buffer (0.3 M sucrose, 2 mM EDTA) with protease inhibitor cocktail (EMD Millipore) and phosphatase inhibitor cocktail (Cell Signaling, Danvers, MA, USA); the pellet was then extracted in TEEN buffer (10 mM Tris, 1 mM EDTA, 1 mM EGTA, 150 mM NaCl) with protease inhibitor cocktail and phosphatase inhibitor cocktail. The protein concentration of the samples was estimated via bicinchoninic acid assay (Thermo Fisher). Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (50 lg/lane) on 4-12% NuPAGE Bis-Tris gels (Invitrogen, Burlington, ON, Canada) with MES running buffer, and transferred to 0.2 lm nitrocellulose using the iBlot Transfer System (Invitrogen). Membranes were blocked with 5% milk in Tris-buffered saline with 0.1% Tween-20 (TBST) for 1 h at 24°C. Primary antibodies were diluted in 5% milk in TBST, and incubated overnight at 4°C at the following concentrations: a-GAD65 (1 : 1000; EMD Millipore), a-GAD67 (1 : 1000; EMD Millipore), a-GABA A Receptor alpha 1 (1 : 1000; Abcam, Cambridge, MA, USA), a-GABA A Receptor alpha 5 (1 : 500; Abcam), a-GABA A Receptor delta (1 : 500; Abcam), and a-GAPDH (1 : 10 000; Sigma-Aldrich, Oakville, ON, Canada). Secondary antibodies were incubated for 1 h at 24°C in 5% milk in TBST (aRabbit-horseradish peroxidase or a-Mouse-horseradish peroxidase as appropriate, 1 : 2000; Cell Signaling). Blots were then developed with chemiluminescent substrate (Amersham ECL Western blotting detection reagents; GE Life Sciences, Mississauga, ON, Canada) and exposed to film.
Statistical analysis
We used linear mixed effects modeling (lme function in R, http:// www.R-project.org) to model power and coherence as linear functions of genotype (transgenic vs. non-transgenic) and, in case of spontaneous activity power and coherence, frequency band, with subjects treated as random effects, thus accounting for acrosssubject variation. Analysis of variance was performed to assess the interaction between genotype and frequency band. Results are expressed as mean AE standard error of the mean (SEM) unless specified differently.
Results

Plaques
We used 6F3D labeling to estimate the numbers of plaques in the hippocampus (HPC) and mPFC. While no plaques were detectable in the nTg animals, we found 10.7 AE 1.3 plaques/ mm 2 in the HPC (Fig. 1a and c ) and 4.6 AE 0.7 plaques/mm 2 in the mPFC (Fig. 1b and c) . These data thus demonstrate the extent of amyloid deposition at this stage of the disease progression in TgF344-AD animals.
Neuronal activity
To assess the effects of genotype on neuronal activity, we analyzed the power of resting neuronal activity in the hippocampus (HPC) and mPFC. In Fig. 2 , resting activity in the HPC of an nTg (ai) and a TgF344-AD (aii) rat is displayed and their power spectra overlaid in (aiii), showing lower power in the low-gamma band in the TgF344-AD animal. Similarly, we show the resting activity in the mPFC of an nTg (bi) and a TgF344-AD (bii) rat, with their power spectra overlaid in (biii), again showing lower power in the low-gamma band of the TgF344-AD animal. F-statistic revealed a significant interaction between genotype and frequency band on the resting activity of the hippocampus (p = 0.016) and of mPFC (p = 1e-4), indicating the effect of genotype in explaining the differences in power between bands. We thus proceeded with post hoc analysis, using linear mixed effects to model the spontaneous activity power with each frequency band as a function of genotype (fixed effect), with subject treated as random effect. This analysis revealed 42.7 AE 4.1% attenuation of resting power in lowgamma band in the TgF344-AD rats in HPC (Fig. 2c , p = 0.0088) and a 47.3 AE 4.7% attenuation of low-gamma band resting power in mPFC (Fig. 2d , p = 0. 0371). Notwithstanding the aforementioned contrasts, it has been previously shown that theta and gamma band power levels per se may not be different between amyloid precursor protein (APP)-deficient and wild-type mice despite cognitive deficits in the former (Zhang et al. 2016) . Accumulating evidence indicates that a more sensitive predictor of cognitive function may be the coupling between the phase of a slow oscillation (i.e., theta) and the amplitude of a faster oscillation (i.e., gamma) because of its role in information processing (Tort et al. 2009; Canolty and Knight 2010; Lisman and Jensen 2013) . PAC is one of the manifestations of cross-frequency coupling exhibited by neuronal network, whereby the phase of a lower frequency modulates the amplitude of a higher frequency oscillation. Such coupling has been observed in a variety of recoding modalities (electroencephalography, magnetoencephalography, electrocorticography, and local field potential) and is prevalent in humans (Palva et al. 2005; Canolty et al. 2006) and rodents (for a review, see Jensen and Colgin 2007) . PAC reflects the temporal coordination of neuronal networks across or within brain regions, although the basic features of excitatory and inhibitory network connectivity that give rise to PAC have not been established.
We focused on the modulation that theta band (3-9 Hz) exerts on gamma band (30-120 Hz), as its importance has been shown in many studies of human neocortex (Canolty et al. 2006; Jensen and Colgin 2007) and in mouse models of AD (Zhang et al. 2016) . These data are displayed in Fig. 3 . The average MI of theta to high-gamma band from the HPC of TgF344-AD rats (0.024 AE 0.004) was significantly reduced (78.9 AE 0.8%, p = 0.05) when compared to that of nTg littermates (0.053 AE 0.001). Similarly, the theta to high-gamma band average MI estimated from the mPFC of TgF344-AD rats (0.029 AE 0.004) was significantly lower (66.7 AE 0.6%, p = 0.04) than that of nTg littermates (0.058 AE 0.001). Altogether these data indicate an impaired functional interaction between the theta and the high-gamma bands in the HPC and mPFC of the transgenic cohort (Fig. 3c) .
Lastly, we examined the coherence between HPC and mPFC since it has been shown that high coherence is correlated with learning (as reviewed in Sigurdsson and Duvarci 2015) and can be evaluated in anesthetized animals (Taxidis et al. 2010; Borjigin et al. 2013) . F-statistic revealed a significant interaction of genotype and frequency band on the HPC-mPFC coherence (p = 1e-4). Post hoc lme indicated a reduced (35.3 AE 6.6%, p = 0.04) coherence in the low-gamma band of TgF344-AD animals (0.028 AE 0.001) when compared to nTg littermates (0.04 AE 0.002).
GABA A receptors expressions
Cross-frequency coupling relies on the dynamic interaction between excitatory and inhibitory neurons, and the attenuated MI of transgenic rats observed here suggests their inhibitory circuitry may be affected (Womelsdorf et al. 2014) . We quantified the expression of GABA A receptor subunits a1, a5, and d, and of the enzymes GAD65 and GAD67 with western blots. We did not find any difference between nTg and TgF344-AD animals (Fig. 4 , a1: p = 0.884, a5: p = 0.9323, d: p = 0.7956, GAD65: p = 0.729, GAD67: p = 0.7713). However, quantification of GAD67-positive cells on immunohistochemical GAD67 staining revealed a reduction in the GAD67-positive cells in the CA1 region of the TgF344-AD rats; and a strong trend toward a decrease in the CA3 region (n = 6; p = 0.0395 for CA1 and p = 0.0545 for CA3, Fig. 5 ).
Discussion
Altogether, our data show neuronal network dysfunction in the early stage of Ab and tau pathologies in TgF344-AD rats. The present work suggests that aberrations in the neuronal network connectivity can precede the alterations in GABAergic terminals levels and neurological symptoms observed in patients (Li et al. 2016) .
The increase in levels of Ab and tau hyperphosphorylation in our model is in line with the data presented by Cohen and colleagues in the TgF344-AD rat model (Cohen et al. 2013) and in human AD brain (Grundke-Iqbal et al. 1986; Kopke et al. 1993; Goedert et al. 1995) . As with patients (Selkoe 2001) , age-dependent Ab accumulation in TgF344-AD rats precedes tauopathy, cognitive disturbance, apoptosis, and neuronal loss (Cohen et al. 2013) . Our plaque data Fig. 2 Resting power. Representative traces recorded in the hippocampus (HPC) of an nTg (ai) and a TgF344-AD (aii) animal. The power spectra in these two animals are overlaid in (aiii) and suggest attenuated power in the low-gamma band in the TgF344-AD rat relative to the nTg animal. Representative traces recorded in the mPFC of an nTg animal (bi) and in the mPFC of a TgF344-AD rat (bii). The corresponding power spectra are overlaid in (biii), indicating lowgamma band power attenuation in the TgF344-AD animal. The bandwise population analysis for the HPC (c) revealed 42.7 AE 4.1% attenuation in the low-gamma band in the TgF344-AD versus in the nTg animals (p = 0.0088); with no differences presently detected in the other bands (theta, p = 0.96; alpha, p = 0.7, beta = 0.23; high gamma, p = 0.31). Likewise, the band-wise population analysis for the mPFC (d) revealed 47.3 AE 4.7% attenuation in the low gamma (p = 0.0371), whereas no differences were detected in the other bands (theta, p = 0.47; alpha, p = 0.07, beta = 0.06; high gamma, p = 0.08). area of hippocampus covered with plaques of 3% in the 16-month-old Tg-F344-AD rats. The tau hyperphosphorylation of our 9-month-old TgF344-AD rats has been reported in a separate study (Joo et al. 2017) : briefly, the 9-month-old Fig. 3 Phase-amplitude coupling and coherence. Representative example of raw (black trace) and filtered recordings (theta in blue, high gamma in red) from the hippocampus (HPC) of an nTg (ai) and a TgF344-AD (bi) rat. Notice similar power levels in TgF344-AD and nTg rats for both theta and high-gamma frequency bands (in contrast to previously discussed low-gamma bands). Mean co-modulation map of an nTg (aii) and a TgF344-AD (bii) rat in the HPC; mean co-modulation map of an nTg (aiii) and a TgF344-AD (biii) rat in the HPC. (c) Theta to high-gamma modulation index was reduced in the HPC (by 78.9 AE 0.8%, p = 0.05) and by 66.7 AE 0.5% (p = 0.04) in the medial prefrontal cortex (mPFC) of TgF344-AD cohort. (d) Coherence between HPC and mPFC was reduced by 35.3 AE 6.6%, p = 0.04 in the low-gamma band of the TgF344-AD cohort.
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TgF344-AD rats show doubling of tau phosphorylation at Ser202/Thr205 and a 1.5-fold increase in tau phosphorylation at Thr231 compared to nTg littermates. These sites of hyperphosphorylation on tau in our TgF344-AD rats are well matched to those exhibiting pronounced phosphorylation in the early stage of AD in patients (Goedert et al. 1995; Kitazawa et al. 2005; Mondragon-Rodriguez et al. 2008) . While hyperphosphorylation of tau leads to tau aggregation and NFT formation in AD patients (Arai et al. 2006) and in TgF344-AD rats (Cohen et al. 2013) , further work is required to provide a mechanistic understanding of the effect of tauopathy progression on neuronal network functioning.
The present work provides the first characterization of the effects of AD pathology on GABA A receptors expression and neuronal network functioning in the HPC and mPFC in the TgF344-AD rat model of Alzheimer's disease at 9 months of age, that is, before the onset of significant cognitive symptomatology. Although the expression of GABA A receptor subunits a1, a5, and d was not different between the two cohorts, the expression levels of a1 and a5 subunits in the hippocampus are a poor predictor of the severity of human AD neuropathology (Rissman et al. 2003) . Further, we found fewer cells expressing the extra synaptic GAD67 protein in the CA1 (and showed a trend in the CA3) region of the transgenic cohort at this time point, in line with the findings in the TgCRND8 mouse model (Krantic et al. 2012; Ma and McLaurin 2014) . The differential localization suggests that GAD65 synthesizes GABA for neurotransmission, whereas GAD67-mediated production is addressed to neuronal activity unrelated to neurotransmission, such as synaptogenesis and protection from neural injury (Pinal and Tobin 1998) . Hence, the denser localization of GAD67 in CA1 and CA3 of Tg344-AD rats may indicate a regional response to early toxicity. The spatial confinement of this response may have resulted in the lack of contrast in GAD67 protein levels on western blots; indeed, we were able to detect differences in the cell numbers. The cellular pathways that result in the GABAergic system degeneration is beyond the scope of this study and may involve the entire GAD protein complex. In support of this notion, the TgCRND8 mouse model of AD shows GAD67 reductions exclusively in neurons of the Cornu Ammonis (Krantic et al. 2012) . Alternatively, GAD67 may have been reduced only in a subset of interneurons, such as parvalbumin-positive cells.
In our experiments, TgF344-AD rats showed attenuated power in low-gamma band, which recapitulates findings in AD patients (Herrmann and Demiralp 2005) and in some (but . The number of GAD67-positive cells in the CA1 and CA3 regions were counted and divided by the area examined: compared to nTg rats, TgF344-AD rats showed a lower number of cells in the CA1 (n = 6 animals; four sections were counted per animal, p = 0.0395) and exhibited a strong trend in the CA3 (n = 6 animals; four sections were counted per animal, p = 0.545). * denotes p < 0.05. not all) mouse models of AD during resting activity (for a review, see Palop and Mucke 2016) . Although the mechanisms have not been fully elucidated, gamma band is known to be tightly related to vascular response (Niessing et al. 2005; Goense and Logothetis 2008; Koch et al. 2009 ) and the cerebrovascular reactivity is compromised early on in AD progression (Dorr et al. 2012; Iturria-Medina et al. 2016) . Further, the HPC and mPFC of TgF344-AD rats exhibited impaired neuronal network dysfunction as shown by the attenuated theta-high gamma PAC, which reflects the temporal coordination of neuronal networks within a region or between different regions (e.g., hippocampal theta phase can modulate neocortical gamma power; Sirota et al. 2008) . This reduction in the modulation index in the HPC and mPFC of TgF344-AD rats compared to those of nTg littermates parallels attenuated theta-gamma coupling in the hippocampus of APP-deficient mice during active walking (Zhang et al. 2016) and in AD patients (for reviews, see Hamm et al. 2015; Sigurdsson and Duvarci 2015) . Further studies are required, however, to identify the features of excitatory and inhibitory network connectivity that give rise to cross-frequency coupling in different anatomical regions.
Hippocampus and mPFC are functionally related and their communication is reflected in coherence (for reviews, see Colgin 2011; Sigurdsson and Duvarci 2015) . Disturbances in oscillatory phase-locking between the HPC and mPFC have been hypothesized to contribute to cognitive deficits in schizophrenia as well as in neurodegenerative disorders (Colgin 2011) . Accordingly, our TgF344-AD rats showed reduced mPFC-HPC coherence, a finding that may have diagnostic potential particularly as recent report using scalp EEG suggested altered phase synchronization between these two areas in Alzheimer's disease patients (Hata et al. 2016) . Further studies are required to examine possible coherence alterations between brain regions not explored in the present work. In APP-deficient mice, on the other hand, phase coherence spectra between the hippocampus and lateral prefrontal cortex during active walking showed no effects of genotype on either theta or gamma band coherence (Zhang et al. 2016) .
Altogether, our data show that TgF344-AD rats exhibit significant neuronal network dysfunction in the early stage of AD pathology. In our previous work (Joo et al. 2017) , we provided evidence that in this early stage of AD pathophysiology, the severity of cortical arteriolar dysfunction is directly related to amyloid coverage of the arteriole. The failure of penetrating arterioles may thus well lead to episodes of ischemia/hypoxia during elevated tissue metabolism (Nishimura et al. 2007; Blinder et al. 2010) . The cortical vascular dysfunction we reported on earlier (Joo et al. 2017 ) and the electrophysiological abnormalities we presently measured in the HPC and mPFC in the absence of significant global morphological changes are likely driven by Ab and tau pathologies. As they precede the onset of cognitive deficits, yet may be assessed non-invasively, these neuronal network dysfunctions have significant clinical diagnostic potential. In addition, our findings support the use of the TgF344-AD rat model for investigation of the prodromal stage of Alzheimer's disease that is thought most amenable to effective treatment.
